Complexity of the HVR-1 quasispecies and disease activity in patients with hepatitis C

European Journal of Clinical Investigation

Volumn 37, Issue 7, 2007, Pages 566-572

  Kumagai, N ^a   Kaneko, F ^a   Tsunematsu, S ^a   Tsuchimoto, K ^a   Tada, S ^b   Saito, H ^b   Hibi, T ^b  

^a KITASATO INSTITUTE HOSPITAL   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Alanine transaminase; Hepatitis C virus; Hyaluronic acid; Hypervariable region

Indexed keywords

ALANINE AMINOTRANSFERASE; HYALURONIC ACID; VIRUS PROTEIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FLUORESCENCE ANALYSIS; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

AGED; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; FEMALE; GENOME, VIRAL; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; VIRAL PROTEINS;

EID: 34250316194     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2007.01825.x     Document Type: Article

References (30)

1. Enomoto N, Sakamoto N, Kurosaki M, Sato C, Marumo F. The hypervariable region of HCV genome changes sequentially with the progression of acute HCV infection to chronic hepatitis. J Hepatol 1993 17 : 415 6.
2. Kurosaki M, Enomoto N, Marumo F, Sato C. Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection. Hepatology 1993 18 : 1293 9.
3. Okamoto H, Kojima M, Okada S, Yoshizawa H, Iizuka H, Tanaka T et al. Genetic drift of hepatitis C virus during an 8·2-year infection in a chimpanzee: variability and stability. Virology 1992 190 : 894 9.
4. Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol 1992 66 : 3225 9.
5. Koizumi K, Enomoto N, Kurosaki M, Murakami T, Izumi N, Marumo F et al. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 1995 22 : 30 5.
6. Yuki N, Hayashi N, Moribe T, Matsushita Y, Tabata T, Inoue T et al. Relation of disease activity during chronic hepatitis C infection to complexity of hypervariable region 1 quasispecies. Hepatology 1997 25 : 439 44.
7. López-Labador FX, Ampurdanès S, Gimènez-Barcons M, Guilera M, Costa J. Jimènez de Anta MT et al. Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b interferon. Hepatology 1999 29 : 897 903.
8. Weiner AJ, Geysen HM, Christophersen C, Hall JE, Mason TJ, Saracco G et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infection. Proc Natl Acad Sci USA 1992 89 : 3468 72.
9. Kato N, Sekiya H, Ootsuyama Y, Nakazawa T, Hijikata T, Ohkoshi S et al. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 1993 67 : 3923 30.
10. Kumagai N, Kuramochi S, Toda K, Iwabuchi N, Tsuchimoto K, Tsunematsu S et al. Assessment of histological features and outcome of interferon therapy in chronic hepatitis C. J Gastroenterol 1996 31 : 69 74.
11. Okamoto H, Sugiyama S, Okada S, Kurai K, Akahane Y, Sugai S et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992 73 : 673 9.
12. Schulhof JC, Molko D, Teoule R. The final deprotection step in oligonucleotide synthesis is reduced to a mild and rapid ammonia treatment by using labile base-protecting groups. Nucleic Acids Res 1987 15 : 397 416.
13. Kumagai N, Takahashi N, Kinoshita M, Tsunematsu S, Tsuchimoto K, Saito H et al. Polymorphism of NS5B protein relates to early clearance of hepatitis C virus by interferon plus ribavirin: a pilot study. J Viral Hepat 2004 11 : 225 35.
14. Toyoda H, Fukuda Y, Koyama Y, Nakano I, Kinoshita M, Hamada T et al. Nucleotid sequence diversity of hypervariable region 1 of hepatitis C virus in Japanese hemophiliacs with chronic hepatitis C and patients with chronic posttransfusion hepatitis C. Blood 1996 88 : 1488 93.
15. Hultman T, Stahl S, Hornes E, Uhlen M. Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucleic Acids Res 1989 17 : 4937 46.
16. Toyoda H, Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T et al. Quasispecies nature of hepatitis C virus and response to alpha interferon: significance as a predictor of direct response to interferon. J Hepatol 1997 26 : 6 13.
17. Hassoba HM, Bzowej N, Berenguer M, Berenguer M, Kim M, Zhou S et al. Evolution of viral quasispecies in interferon-treated patients with chronic hepatitis C virus infection. J Hepatol 1999 31 : 618 27.
18. Ueda E, Enomoto N, Sakamoto N, Hamano K, Sato C, Izumi N et al. Changes of HCV quasispecies during combination therapy with interferon and ribavirin. Hepatol Res 2004 29 : 89 96.
19. Abbate I, Iacono OL, Stefano RD, Cappiello G, Giratdi E, Longo R et al. HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin. J Hepatol 2004 40 : 831 6.
20. Mcallister J, Casino C, Davidson F, Power J, Lawlor E, Yap PL et al. Long-term evolution of hypervariable region of hepatitis C virus in a common-source-infected cohort. J Virol 1998 72 : 4893 905.
21. Lin HJ, Seefe LB, Barbosa L, Hollinger B. Occurrence of identical hypervariable region 1 sequences of hepatitis c virus in transfusion recipients and their respective blood donors: divergence over time. Hepatology 2001 34 : 424 9.
22. Laskus T, Wilkinson J, Gallegos-Orozco JF, Radkowski M, Adair DM, Nowicki M et al. Analysis of hepatitis C virus quasispecies transmission and evolution in patients infected through blood transfusion. Gastroenterology 2004 127 : 764 76.
23. Ray SC, Fanning L, Wang XH, Netski DM, Kenny-Walsh E, Thomas DL. Divergent and evolution after a common-source outbreak of hepatitis C virus. J Exp Med 2005 201 : 1753 9.
24. Cox AL, Mosburger T, Mao Q, Liu Z, Wang XH, Yang HC et al. Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med 2005 201 : 1741 52.
25. Sitia G, Cella D, Mitri MSD, Novati R, Foppa CU, Perackis K et al. Evolution of the E2 region of hepatitis c virus in an infant infected by mother-to-infant transmission. J Med Virol 2001 64 : 476 81.
26. Gerotto M, Resti M, Dal Pero F, Migliorato I, Alberti A, Bortolotti F. Evolution of hepatitis C virus quasispecies in children with chronic hepatitis C. Infection 2006 34 : 62 5.
27. Nagayama K, Kurosaki M, Enomoto N, Mayasaka Y, Marumo F, Sato C. Characteristics of hepatitis C virus genome associated with disease progression. Hepatology 2000 31 : 745 50.
28. Ramadori G, Zöhrens G, Manns M, Rieder H, Dienes HP, Hess G et al. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. Eur J Clin Invest 1991 21 : 323 30.
29. Ueno T, Inuzuka S, Torimura T, Tamaki S, Koh H, Kin M et al. Serum hyaluronate reflets hepatic sinusoidal capillarization. Gastroenterology 1993 105 : 475 81.
30. Parës A, Deulofeu R, Gimënez A, Caballería L, Bruguera M, Caballería J et al. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology 1996 24 : 1399 403.